Literature DB >> 19218032

Outcomes for the extremely premature infant: what is new? And where are we going?

Charlene M T Robertson1, Man-Joe Watt, Irina A Dinu.   

Abstract

Two approaches were taken to determine what is new and where we are going in terms of outcomes for the extremely premature infant: publications from 2004 to 2007 were reviewed, and the 30-year outcome at the authors' institutions was assessed. Recent literature documents improving early childhood outcomes in the face of improved survival. Childhood cerebral palsy prevalence rates have been reported to be as low as 19 per 1000 live births for infants born at 20-27 weeks gestation. Vision and hearing loss have been reported in fewer than 1% of survivors. The rate of overall intellectual impairment has not improved, although impairment was reduced in a recent trial of caffeine therapy for apnea of prematurity, and this remains an important area for study. In sum, recent findings herald a more positive perspective on the outcome for extremely premature survivors. It can thus be expected that new intensive-care trials will attempt to reduce the proportion of survivors with adverse outcomes. Childhood assessments will have a greater focus on function and participation. Information on improved outcomes for preterm infants will inform guidelines of decision making used to help parents to determine what is best for their child. The audit component of follow-up studies will expand and more cohort and trial studies will become multicenter, national, and international.

Entities:  

Mesh:

Year:  2009        PMID: 19218032     DOI: 10.1016/j.pediatrneurol.2008.09.017

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  19 in total

1.  High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.

Authors:  Sameh Mohammed; Islam Nour; Abd Elazeez Shabaan; Basma Shouman; Hesham Abdel-Hady; Nehad Nasef
Journal:  Eur J Pediatr       Date:  2015-02-03       Impact factor: 3.183

Review 2.  Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts.

Authors:  Shenandoah Robinson
Journal:  J Neurosurg Pediatr       Date:  2012-03       Impact factor: 2.375

3.  Cerebral palsy among term and postterm births.

Authors:  Dag Moster; Allen J Wilcox; Stein Emil Vollset; Trond Markestad; Rolv Terje Lie
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

4.  Brain visual impairment in childhood: mini review.

Authors:  N Kozeis
Journal:  Hippokratia       Date:  2010-10       Impact factor: 0.471

5.  Maternal Education Level Predicts Cognitive, Language, and Motor Outcome in Preterm Infants in the Second Year of Life.

Authors:  Kousiki Patra; Michelle M Greene; Aloka L Patel; Paula Meier
Journal:  Am J Perinatol       Date:  2016-02-18       Impact factor: 1.862

6.  Active Treatment of Infants Born at 22-25 Weeks of Gestation in California, 2011-2018.

Authors:  Xuxin Chen; Tianyao Lu; Jeffrey Gould; Susan R Hintz; Deirdre J Lyell; Xiao Xu; Lillian Sie; Matthew Rysavy; Alexis S Davis; Henry C Lee
Journal:  J Pediatr       Date:  2022-06-15       Impact factor: 6.314

Review 7.  Caffeine therapy in preterm infants.

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  World J Clin Pediatr       Date:  2015-11-08

8.  Caesarean section and neonatal survival and neurodevelopmental impairments in preterm singleton neonates.

Authors:  Abhay Lodha; Krystyna Ediger; Dianne Creighton; Selphee Tang; Arijit Lodha; Stephen Wood
Journal:  Paediatr Child Health       Date:  2019-04-22       Impact factor: 2.253

Review 9.  Apnea of prematurity: from cause to treatment.

Authors:  Jing Zhao; Fernando Gonzalez; Dezhi Mu
Journal:  Eur J Pediatr       Date:  2011-02-08       Impact factor: 3.183

10.  Perinatal factors associated with early neonatal deaths in very low birth weight preterm infants in Northeast Brazil.

Authors:  Eveline Campos Monteiro de Castro; Álvaro Jorge Madeiro Leite; Maria Fernanda Branco de Almeida; Ruth Guinsburg
Journal:  BMC Pediatr       Date:  2014-12-20       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.